MXCTMaxCyte, Inc.May 12, 2026Q1 2026
Read transcript →MaxCyte, Inc. (MXCT) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$1.11
+3.27%
Mkt Cap $112.48M
MXCTMaxCyte, Inc.May 12, 2026MXCTMaxCyte, Inc.Mar 24, 2026Q4 2025
Read transcript →MXCTMaxCyte, Inc.Nov 12, 2025Q3 2025
Read transcript →MXCTMaxCyte, Inc.Aug 7, 2025Q2 2025
Read transcript →MXCTMaxCyte, Inc.May 10, 2025Q1 2025
Read transcript →MXCTMaxCyte, Inc.Mar 11, 2025Q4 2024
Read transcript →MXCTMaxCyte, Inc.Nov 6, 2024Q3 2024
Read transcript →MXCTMaxCyte, Inc.Aug 7, 2024Q2 2024
Read transcript →MXCTMaxCyte, Inc.May 11, 2024Q1 2024
Read transcript →MXCTMaxCyte, Inc.Mar 12, 2024Q4 2023
Read transcript →MXCTMaxCyte, Inc.Nov 8, 2023Q3 2023
Read transcript →MXCTMaxCyte, Inc.Aug 9, 2023Q2 2023
Read transcript →MXCTMaxCyte, Inc.May 12, 2023Q1 2023
Read transcript →MXCTMaxCyte, Inc.Mar 15, 2023Q4 2022
Read transcript →MXCTMaxCyte, Inc.Nov 12, 2022Q3 2022
Read transcript →MXCTMaxCyte, Inc.Aug 10, 2022Q2 2022
Read transcript →MXCTMaxCyte, Inc.May 9, 2022Q1 2022
Read transcript →MXCTMaxCyte, Inc.Mar 22, 2022Q4 2021
Read transcript →MXCTMaxCyte, Inc.Nov 13, 2021Q3 2021
Read transcript →MXCTMaxCyte, Inc.Sep 13, 2021Q2 2021
Read transcript →